Huntleigh Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Huntleigh Advisors's MDT Position: Q2 2026 in Review
Huntleigh Advisors increased its Medtronic (MDT) stake by 1.8% in Q2 2026, buying an estimated $11.4K and bringing the position to 7,824 shares worth $612K. The position accounts for 0.09% of the portfolio, ranked #180.
Huntleigh Advisors first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $681K in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Huntleigh Advisors held 7,824 shares of Medtronic worth $612K as of Q2 2026.
- Huntleigh Advisors bought 141 Medtronic shares in Q2 2026, an estimated $11.4K.
- Medtronic made up 0.09% of Huntleigh Advisors's portfolio in Q2 2026, its #180 holding.
- Huntleigh Advisors first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
- Huntleigh Advisors's Medtronic position peaked at $681K in Q3 2025.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Huntleigh Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.